Related Experiment Videos
Serum thyroglobulin measurements in differentiated thyroid cancer
1Dipartimento di Scienze Mediche e Chirurgiche, Università di Padova, Padua, Italy.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 16, 2000
Summary
Serum thyroglobulin (Tg) is not useful for diagnosing thyroid cancer before surgery. Postoperative Tg levels help monitor differentiated thyroid carcinoma (DTC) patients for residual or metastatic disease.
Area of Science:
- Endocrinology
- Oncology
- Clinical Chemistry
Background:
- Serum thyroglobulin (Tg) levels are often elevated in pathological conditions.
- Preoperative Tg assays lack utility in differentiating benign from malignant thyroid disease.
Purpose of the Study:
- To evaluate the role of serum Tg measurements in the postoperative follow-up of differentiated thyroid carcinoma (DTC) patients.
- To determine the significance of Tg levels in identifying residual or metastatic thyroid tissue.
Main Methods:
- Serum Tg levels were measured in patients post-total thyroidectomy.
- Tg levels were assessed in patients on and off thyroid hormone suppressive therapy.
- Changes in Tg levels during thyroid stimulating hormone (TSH) suppression were monitored.
Main Results:
- Undetectable serum Tg concentrations indicated an absence of residual thyroid tissue or metastases post-thyroidectomy.
- Detectable serum Tg levels, irrespective of suppressive therapy, suggested the presence of residual or metastatic thyroid tissue.
- An increasing Tg level during TSH suppression warranted further investigation.
Conclusions:
- Serum Tg measurement is a valuable tool for monitoring DTC patients postoperatively.
- Detectable Tg levels post-thyroidectomy signify residual or metastatic disease.
- Monitoring Tg trends, especially during TSH suppression, is crucial for patient management.